Trial reportWorld journal of urology2025
Effectiveness and safety of ultra-slow full power shockwave lithotripsy compared to mini-percutaneous nephrolithotomy and retrograde intrarenal surgery for treatment of lower calyceal stone between 1 and 2 cm with high attenuation value.
Trial report in World journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis prospective randomized study compared the effectiveness and safety of ultra-slow full power shockwave lithotripsy (ultraslow SWL), mini-percutaneous nephrolithotomy (mini-PNL), and retrograde intrarenal surgery (RIRS) for 1-2 cm lower calyceal stone with HU above 1000.
methods360 patients were randomized with stratification according to stone size using a block randomization to: (1) Ultraslow SWL; (2) Mini-PNL; or (3) RIRS. Primary outcomes were stone-free rates (SFR) and complications with blinding of assessors. Our follow-up protocol featured a non-contrast CTUT after 3 months for Ultraslow SWL while 1 month for both mini-PNL and RIRS groups, confirming stone-free status. The SFR was stratified as follow: true stone-free (0 mm), residual fragments ≤ 2 mm, residual fragments 3-4 mm, and failure (more than 4 mm). Secondary outcomes included operative parameters and hospitalization. Multinominal logistic regression was used for significant findings to identify predictors of success or failure.
resultsMini-PNL showed superior SFR (95%) versus RIRS (85.8%) and SWL (76.7%) (p = 0.007). Mini-PNL showed the lowest rates of residual stones (0.8% for fragments ≤ 2 mm, 0.8% for fragments 3-4 mm, and 3.3% for failure), while SWL had the highest residual stone (5% for fragments ≤ 2 mm, 3.3% for fragments 3-4 mm, and 15% for failure), with RIRS demonstrating intermediate outcomes (3.3% for fragments ≤ 2 mm, 3.3% for fragments 3-4 mm, and 7.5% for failure). All techniques had comparable (p = 0.110) Clavien Dindo I-II complications (pain, vomiting, colic, hematuria, skin ecchymosis, and fever/UTI) and managed conservatively with analgesics, hydration, or antibiotics, with no major complications (Grade III-V). However, interpretation of comparative outcomes must be cautious due to methodological limitations such as differing follow-up timing.
conclusionMini-PNL achieved higher SFR, its invasiveness and radiation exposure warrant consideration. However, the comparison between RIRS and ultraslow SWL success suggests ultraslow SWL may benefit patients with moderately sized lower pole stones with high attenuation values, especially who wish to avoid invasive surgery or are considered unfit for anesthesia. The results are encouraging but preliminary and require confirmation. However, some limitations were heterogeneous follow-up imaging intervals, absence of anatomical data, lack of stone composition analysis, and baseline stone volume imbalance. Therefore, future studies should evaluate long-term outcomes and cost-effectiveness, and consider our limitations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.